IGF2BP3 and familial pancreatic carcinoma: In the LinkedOmics dataset, the high expression of IGF2BP1, IGF2BP2, and IGF2BP3 was significantly associated with the poor overall survival of pancreatic cancer patients (Fig. 3a).